Toxicology study in Haemostasis
Haemostasis is the first step of wound healing after the wound ceases to bleed due to a mechanism of Coagulation. If the process of haemostasis does not occur it might lead to an excess loss of blood which can lead to the hypovolemic shock or even death of the individual. The liquid monomer component of Methyl Methacrylate is a cytotoxic component which is associated frequently with fatal cardiorespiratory collapse in cases of Implantations of acrylic cements. And some of the cases where the usage of the NSAIDS may lead to an increased tendency of bleeding which can be considered fatal some times and thus the study of the effect of Haemostasis play a very important role in the field of Toxicology. Hence the study of the Knowledge is essential in cases of drug effects on Haemostasis.
- Blood glucose
- Levels of blood gases
- Blood oxygen content
Related Conference of Toxicology study in Haemostasis
6th International Conference on Clinical Pharmacology and Toxicology
Toxicology study in Haemostasis Conference Speakers
Recommended Sessions
- Applications of Toxicology
- Cardiovascular Toxicology
- Chemical Carcinogenesis
- Clinical Toxicology
- Environmental Toxicology
- Forensic Toxicology
- Genetic Toxicology
- Immunotoxicology
- Molecular Toxicology
- Neurotoxicology
- Reproductive and Developmental Toxicology
- Systemic Toxicology
- Toxicity Testing`
- Toxicology and Risk Assessment (TRA)
- Toxicology study in Effects on Liver and Kidney
- Toxicology study in Haemostasis
- Toxicopathology
Related Journals
Are you interested in
- Adverse Drug Reactions and Pharmacovigilance - clinicalpharmacology2025 (Canada)
- Cardiovascular Pharmacology - clinicalpharmacology2025 (Canada)
- Clinical Toxicology of Drugs of Abuse - clinicalpharmacology2025 (Canada)
- Clinical Trials and Regulatory Affairs - clinicalpharmacology2025 (Canada)
- Drug Interactions and Polypharmacy - clinicalpharmacology2025 (Canada)
- Emerging Trends in Clinical Pharmacology - clinicalpharmacology2025 (Canada)
- Environmental and Occupational Toxicology - clinicalpharmacology2025 (Canada)
- Future Directions in Clinical Pharmacology and Toxicology - clinicalpharmacology2025 (Canada)
- Innovations in Drug Development and Therapeutics - clinicalpharmacology2025 (Canada)
- Natural Products and Toxicology - clinicalpharmacology2025 (Canada)
- Neuropharmacology and Toxicology - clinicalpharmacology2025 (Canada)
- Pediatric and Geriatric Pharmacology - clinicalpharmacology2025 (Canada)
- Pharmacogenomics and Personalized Medicine - clinicalpharmacology2025 (Canada)
- Pharmacokinetics and Pharmacodynamics - clinicalpharmacology2025 (Canada)
- Toxicology and Risk Assessment - clinicalpharmacology2025 (Canada)